Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Accounts Payables (2020 - 2026)

MDxHealth has reported Accounts Payables over the past 7 years, most recently at $12.1 million for Q1 2026.

  • For Q1 2026, Accounts Payables changed N/A year-over-year to $12.1 million; the TTM value through Mar 2026 reached $12.1 million, changed N/A, while the annual FY2025 figure was $10.3 million, 29.11% up from the prior year.
  • Accounts Payables was $12.1 million for Q1 2026 at MDxHealth, up from $10.3 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $12.1 million in Q1 2026 and bottomed at $8.0 million in Q4 2024.
  • The 5-year median for Accounts Payables is $10.2 million (2022), against an average of $9.9 million.
  • Year-over-year, Accounts Payables surged 36.53% in 2022 and then decreased 13.43% in 2023.
  • Over 5 years, Accounts Payables stood at $10.2 million in 2022, then fell by 13.43% to $8.8 million in 2023, then fell by 9.19% to $8.0 million in 2024, then rose by 29.11% to $10.3 million in 2025, then rose by 16.85% to $12.1 million in 2026.
  • The last three reported values for Accounts Payables were $12.1 million (Q1 2026), $10.3 million (Q4 2025), and $8.0 million (Q4 2024) per Business Quant data.